Drug companies are not able to see a physician’s prescribing habits in New Hampshire, according to Tuesday’s ruling in a federal appeals court.
Reps often would have a detailed dossier on the doctor prior to any interaction, and can tailor their pitch and approach based on prescribing trends. It would be interesting to see how they do without that information.
Thanks to the WSJ Health Blog for picking up my Tweet on the subject.
topics: new hampshire, drug reps
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
